BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9440585)

  • 1. Benefit of heparin in central venous and pulmonary artery catheters: a meta-analysis of randomized controlled trials.
    Randolph AG; Cook DJ; Gonzales CA; Andrew M
    Chest; 1998 Jan; 113(1):165-71. PubMed ID: 9440585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah PS; Shah VS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002772. PubMed ID: 18425882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
    Shah PS; Shah N
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005983. PubMed ID: 24569952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.
    Chaukiyal P; Nautiyal A; Radhakrishnan S; Singh S; Navaneethan SD
    Thromb Haemost; 2008 Jan; 99(1):38-43. PubMed ID: 18217132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters.
    Akl EA; Karmath G; Yosuico V; Kim SY; Barba M; Sperati F; Cook D; Schünemann HJ
    Cochrane Database Syst Rev; 2007 Jul; (3):CD006468. PubMed ID: 17636845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
    Shah PS; Shah N
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005983. PubMed ID: 17943871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials.
    Randolph AG; Cook DJ; Gonzales CA; Brun-Buisson C
    Crit Care Med; 1998 Aug; 26(8):1452-7. PubMed ID: 9710109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2001; (3):CD002772. PubMed ID: 11687025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis.
    Vidal E; Sharathkumar A; Glover J; Faustino EV
    J Thromb Haemost; 2014 Jul; 12(7):1096-109. PubMed ID: 24801495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of heparin-bonded central venous catheters on the incidence of catheter-related thrombosis and infection in children and adults.
    Long DA; Coulthard MG
    Anaesth Intensive Care; 2006 Aug; 34(4):481-4. PubMed ID: 16913346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin for prolonging peripheral intravenous catheter use in neonates.
    Shah PS; Ng E; Sinha AK
    Cochrane Database Syst Rev; 2002; (4):CD002774. PubMed ID: 12519576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose versus high-dose heparin locks for hemodialysis catheters: a systematic review and meta-analysis.
    Han X; Yang X; Huang B; Yuan L; Cao Y
    Clin Nephrol; 2016 Jul; 86(7):1-8. PubMed ID: 27191662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central venous catheter replacement strategies: a systematic review of the literature.
    Cook D; Randolph A; Kernerman P; Cupido C; King D; Soukup C; Brun-Buisson C
    Crit Care Med; 1997 Aug; 25(8):1417-24. PubMed ID: 9267959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature.
    Randolph AG; Cook DJ; Gonzales CA; Pribble CG
    Crit Care Med; 1996 Dec; 24(12):2053-8. PubMed ID: 8968276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of nosocomial bloodstream infections: effectiveness of antimicrobial-impregnated and heparin-bonded central venous catheters.
    Marin MG; Lee JC; Skurnick JH
    Crit Care Med; 2000 Sep; 28(9):3332-8. PubMed ID: 11008998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions other than anticoagulants and systemic antibiotics for prevention of central venous catheter-related infections in children with cancer.
    Arora RS; Roberts R; Eden TO; Pizer B
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007785. PubMed ID: 21154387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do anticoagulation with heparin and protamine reversal alter thrombogenicity of coated and noncoated pulmonary artery catheters?
    Youngberg JA; Kaye AD; Anwar M
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4):405-9. PubMed ID: 10468252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefit of heparin in peripheral venous and arterial catheters: systematic review and meta-analysis of randomised controlled trials.
    Randolph AG; Cook DJ; Gonzales CA; Andrew M
    BMJ; 1998 Mar; 316(7136):969-75. PubMed ID: 9550955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.